Vaxfab Enterprises Completes Major Allotment of 2.04 Crore Warrants and 21.27 Lakh Equity Shares

2 min read     Updated on 13 Jan 2026, 06:39 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Vaxfab Enterprises Limited has completed allotment of 2,04,04,372 fully convertible warrants at ₹21.02 per share to 50 investors on preferential basis, convertible within 18 months. Additionally, 21,27,689 equity shares were issued upon warrant conversion by 41 investors at the same price. The allotments increased the company's paid-up share capital to ₹10,52,76,890 comprising 1,05,27,689 equity shares. The Board also corrected previous typographical errors in warrant numbers during their January 12, 2026 meeting.

29855348

*this image is generated using AI for illustrative purposes only.

Vaxfab Enterprises Limited has completed a substantial capital raising initiative through the allotment of fully convertible warrants and equity shares, marking a significant milestone in the company's expansion plans. The Board of Directors approved these allotments during their meeting held on January 12, 2026.

Warrant Allotment Details

The company has allotted 2,04,04,372 fully convertible warrants to 50 investors through preferential allotment. Each warrant is convertible into equivalent fully paid-up equity shares within a maximum period of 18 months from the allotment date.

Parameter: Details
Total Warrants Allotted: 2,04,04,372
Issue Price: ₹21.02 per warrant
Face Value: ₹10.00 per share
Number of Investors: 50
Conversion Period: Maximum 18 months
Allotment Type: Preferential basis

The warrant allotment includes major allocations to entities such as Sparkling Tradewing LLP (19,98,097 warrants), Balmukund Tradelink Private Limited (19,74,310 warrants), and Markand Tradeventure LLP (19,55,281 warrants). Individual investors also participated significantly, with allocations ranging from 47,574 to 7,13,606 warrants per investor.

Equity Share Conversion

Simultaneously, the company issued 21,27,689 equity shares upon conversion of existing warrants by 41 investors. These shares were allotted at the same price of ₹21.02 per share, representing the exercise of previously allotted warrants.

Conversion Details: Amount
Equity Shares Issued: 21,27,689
Conversion Price: ₹21.02 per share
Total Consideration: ₹4,47,24,022.78
Number of Converting Investors: 41

Notable conversions include Mitesh Dineshbhai Patel and Seema Miteshkumar Patel, who each converted 3,09,229 warrants, and Mita Hitesh Ajmera, who converted 2,37,874 warrants into equity shares.

Impact on Share Capital

Following these allotments, Vaxfab Enterprises' paid-up equity share capital has increased substantially. The company's capital structure has been strengthened through this fundraising exercise.

Capital Structure: Before After
Paid-up Share Capital: ₹8,40,00,000 (estimated) ₹10,52,76,890
Total Equity Shares: 84,00,000 (estimated) 1,05,27,689
Face Value per Share: ₹10.00 ₹10.00

Regulatory Compliance and Corrections

The company also addressed typographical errors from its previous submission dated January 12, 2026. The corrected figures show 2,04,04,372 warrants allotted instead of the previously mentioned 2,04,04,371, and Ms. Hema Hardik Parikh's allocation was corrected to 1,90,294 warrants instead of 2,85,442.

All allotments comply with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The equity shares allotted upon warrant conversion rank pari-passu with existing equity shares of the company. The Board meeting commenced at 8:00 PM and concluded at 8:30 PM on January 12, 2026, with Managing Director Ravindra Ashokbhai Joshi overseeing the proceedings.

Historical Stock Returns for Vaxfab Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+3.09%+10.26%+31.29%+153.83%+307.58%+14.34%
Vaxfab Enterprises
View in Depthredirect
like16
dislike

Vaxfab Enterprises Completes Major Capital Raise Through Preferential Allotment of Warrants and Equity Shares

2 min read     Updated on 12 Jan 2026, 09:07 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Vaxfab Enterprises Limited completed a major capital raising initiative through preferential allotment of 2,04,04,371 warrants and conversion of 21,27,689 equity shares at ₹21.02 each. The Board approved this on January 12, 2026, involving 50 investors for warrant allotment and 41 investors for share conversion. The company's paid-up share capital increased to ₹10,52,76,890 comprising 1,05,27,689 equity shares, strengthening its capital structure significantly.

29777870

*this image is generated using AI for illustrative purposes only.

Vaxfab Enterprises Limited has successfully completed a significant capital raising exercise through the preferential allotment of warrants and equity shares. The Board of Directors approved this strategic move on January 12, 2026, marking a substantial expansion of the company's equity base.

Warrant Allotment Details

The company allotted 2,04,04,371 fully convertible warrants to investors on a preferential basis. These warrants carry specific terms and conditions designed to provide flexibility to both the company and investors.

Parameter: Details
Total Warrants Allotted: 2,04,04,371
Face Value: ₹10.00 per warrant
Issue Price: ₹21.02 per warrant
Conversion Period: Maximum 18 months
Number of Investors: 50
Investor Category: Public

The warrants are convertible into equivalent fully paid-up equity shares at the option of allottees within the specified timeframe. Upon conversion, the resulting equity shares will rank pari-passu with existing equity shares of the company.

Equity Share Conversion

Simultaneously, the company completed the conversion of 21,27,689 warrants into equity shares. This conversion represents the exercise of previously outstanding warrants by existing warrant holders.

Conversion Details: Amount
Shares Converted: 21,27,689
Conversion Price: ₹21.02 per share
Total Value: ₹4,47,24,022.78
Number of Converting Investors: 41

The conversion process involved 41 investors who exercised their warrants at the predetermined price. The warrant exercise price structure included ₹5.26 paid at the time of initial warrant allotment and ₹15.77 paid at conversion.

Impact on Share Capital

Following these transactions, Vaxfab Enterprises experienced a significant increase in its paid-up equity share capital. The company's capital structure has been strengthened through this preferential allotment process.

Capital Structure: Before After
Paid-up Share Capital: Not specified ₹10,52,76,890
Total Equity Shares: Not specified 1,05,27,689
Face Value per Share: ₹10.00 ₹10.00

Investor Participation

The allotment attracted diverse participation from individual investors and corporate entities. Major warrant allocations included significant investments from limited liability partnerships and individual investors. Notable allocations ranged from 47,574 warrants to 1,998,097 warrants per investor, demonstrating varied investment levels across the investor base.

The successful completion of both warrant allotment and equity conversion reflects strong investor confidence in the company's prospects. All participating investors fall under the public category, indicating broad-based interest in the company's growth story. The Board meeting commenced at 8:00 PM and concluded at 8:30 PM on January 12, 2026, efficiently completing the approval process for these significant corporate actions.

Historical Stock Returns for Vaxfab Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+3.09%+10.26%+31.29%+153.83%+307.58%+14.34%
Vaxfab Enterprises
View in Depthredirect
like20
dislike
More News on Vaxfab Enterprises
Explore Other Articles
45.69
+1.37
(+3.09%)